Next Article in Journal
Theoretical Analysis of Critical Flowable Physical Gel Cross-Linked by Metal Ions and Polyacrylamide-Derivative Associating Polymers Containing Imidazole Groups
Next Article in Special Issue
Preparation and Property Evaluation of Conductive Hydrogel Using Poly (Vinyl Alcohol)/Polyethylene Glycol/Graphene Oxide for Human Electrocardiogram Acquisition
Previous Article in Journal
Statistical and Dynamical Properties of Topological Polymers with Graphs and Ring Polymers with Knots
Previous Article in Special Issue
Photodeprotectable N-Alkoxybenzyl Aromatic Polyamides
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview
Polymers 2017, 9(7), 255; https://doi.org/10.3390/polym9070255

Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment

1
Laboratory of Building Energy-Saving Technology Engineering, College of Material Science and Engineering, Jilin Jianzhu University, Changchun 130118, Jilin, China
2
Department of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, China
3
School of Phermaceuticel Science and Technology, Dalian University of Technology, Dalian 116024, Liaoning, China
4
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, Jilin, China
*
Authors to whom correspondence should be addressed.
Academic Editors: Chih-Feng Huang, Jinlian Hu and Rui Xiao
Received: 12 May 2017 / Revised: 19 June 2017 / Accepted: 25 June 2017 / Published: 29 June 2017
(This article belongs to the Special Issue Functionally Responsive Polymeric Materials)
Full-Text   |   PDF [5539 KB, uploaded 30 June 2017]   |  

Abstract

The glucose-sensitive drug delivery systems based on glucose oxidase (GOD), which exhibit highly promising applications in diabetes therapy, have attracted much more interest in recent years. The self-regulated drug delivery systems regulate drug release by glucose concentration automatically and continuously to control the blood glucose level (BGL) in normoglycemic state. This review covers the recent advances at the developments of GOD-based glucose-sensitive drug delivery systems and their in vivo applications for diabetes treatment. The applications of GOD-immobilized platforms, such as self-assembly layer-by-layer (LbL) films and polymer vesicles, cross-linking hydrogels and microgels, hybrid mesoporous silica nanoparticles, and microdevices fabricated with insulin reservoirs have been surveyed. The glucose-sensitive drug delivery systems based on GOD are expected to be a typical candidate for smart platforms for potential applications in diabetes therapy. View Full-Text
Keywords: glucose oxidase; glucose sensitivity; drug delivery; diabetes therapy glucose oxidase; glucose sensitivity; drug delivery; diabetes therapy
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Zhao, L.; Wang, L.; Zhang, Y.; Xiao, S.; Bi, F.; Zhao, J.; Gai, G.; Ding, J. Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment. Polymers 2017, 9, 255.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Polymers EISSN 2073-4360 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top